These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 26298709)
1. Growth Inhibition Accompanied by MOB1 Upregulation in Human Acute Lymphoid Leukemia Cells by 3-Deazaneplanocin A. Shen J; Su J; Wu D; Zhang F; Fu H; Zhou H; Xu M Biochem Genet; 2015 Oct; 53(9-10):268-79. PubMed ID: 26298709 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells. Bouzelfen A; Kora H; Alcantara M; Bertrand P; Latouche JB; Jardin F Leuk Res; 2017 Sep; 60():53-57. PubMed ID: 28651105 [TBL] [Abstract][Full Text] [Related]
3. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170 [TBL] [Abstract][Full Text] [Related]
4. The specific alteration of histone methylation profiles by DZNep during early zebrafish development. Ostrup O; Reiner AH; Aleström P; Collas P Biochim Biophys Acta; 2014 Nov; 1839(11):1307-15. PubMed ID: 25260724 [TBL] [Abstract][Full Text] [Related]
5. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Lee JK; Kim KC Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322 [TBL] [Abstract][Full Text] [Related]
6. 3-Deazaneplanocin A suppresses aggressive phenotype-related gene expression in an oral squamous cell carcinoma cell line. Hatta M; Naganuma K; Kato K; Yamazaki J Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):269-73. PubMed ID: 26505792 [TBL] [Abstract][Full Text] [Related]
7. 3-Deazaneplanocin A is a promising therapeutic agent for ovarian cancer cells. Shen L; Cui J; Pang YX; Ma YH; Liu PS Asian Pac J Cancer Prev; 2013; 14(5):2915-8. PubMed ID: 23803053 [TBL] [Abstract][Full Text] [Related]
8. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells. Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells. Liu M; Ge Y; Payton SG; Aboukameel A; Buck S; Flatley RM; Haska C; Mohammad R; Taub JW; Matherly LH Clin Cancer Res; 2006 Jan; 12(2):608-16. PubMed ID: 16428507 [TBL] [Abstract][Full Text] [Related]
10. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia. Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427 [TBL] [Abstract][Full Text] [Related]
12. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731 [TBL] [Abstract][Full Text] [Related]
13. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia]. Jia JS; Salvatore S Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015 [TBL] [Abstract][Full Text] [Related]
14. S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition. Hayden A; Johnson PW; Packham G; Crabb SJ Breast Cancer Res Treat; 2011 May; 127(1):109-19. PubMed ID: 20556507 [TBL] [Abstract][Full Text] [Related]
15. [Effects of decitabine against acute T lymphoblastic leukemia cell line Molt4]. Liu J; Huang C; Cheng H; Tang G; Hu X; Zhou H; Wang J; Yang J Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):230-4. PubMed ID: 25854468 [TBL] [Abstract][Full Text] [Related]
18. 3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death. Tam EK; Nguyen TM; Lim CZ; Lee PL; Li Z; Jiang X; Santhanakrishnan S; Tan TW; Goh YL; Wong SY; Yang H; Ong EH; Hill J; Yu Q; Chai CL ChemMedChem; 2015 Jan; 10(1):173-82. PubMed ID: 25319940 [TBL] [Abstract][Full Text] [Related]
19. [Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia]. Zemliakova VV; Strel'nikov VV; Zborovskaia IB; Balukova OV; Maĭorova OA; Vasil'ev EV; Zaletaev DV; Nemtsova MV Mol Biol (Mosk); 2004; 38(6):966-72. PubMed ID: 15612580 [TBL] [Abstract][Full Text] [Related]
20. [Experiment study of PHI on histone methylation and acetylation in Molt-4 cells]. Huang YQ; Ma XD; Zhen RJ; Chiao JW; Liu DL Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):612-5. PubMed ID: 18246819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]